Fukushima K, Watanabe H, Takeo K, Nomura M, Asahi T, Yamashita K
Department of Biochemistry, Sasaki Institute, Tokyo, Japan.
Arch Biochem Biophys. 1993 Jul;304(1):144-53. doi: 10.1006/abbi.1993.1332.
Recombinant human lymphotoxin (rhLT) produced by CHO cells transfected with human LT genomic DNA was purified to homogeneity, but approximately 5% of the molecules were devoid of the last two amino terminal residues. A peptide N-glycosylated at Asn62 (Tr-45) and one partially O-glycosylated at Thr7 (Tr-14) on cleavage with trypsin were separated by reverse phase HPLC. The N-linked sugar chains of Tr-45 were released quantitatively as oligosaccharides on hydrazinolysis (100 degrees C, 8 h), followed by N-acetylation. After being reduced with either NaB3H4 or NaB2H4, their structures were determined by a combination of serial lectin affinity chromatography, exoglycosidase digestion, and methylation analysis: 82.7% of the sugar chains occur as biantennary complex-type sugar chains, the remainder being C-2 and C-2,4/C-2,6 branched triantennary, and C-2,4 and C-2,6 branched tetraantennary complex-type sugar chains with a fucosylated mannose core. Their sialic acid residues occur only as the Neu5Ac alpha 2-->3Gal group. The clearance velocity from the bloodstream dramatically increased with desialylation, and rhLT tends to have accumulated in the kidney, indicating that there may exist other mechanisms for clearance from the circulation besides the galactose-binding protein in hepatocytes and the filtration system of the kidney. Desialylated rhLT showed a lectin-like binding character to uromodulin similar to that of tumor necrosis factor, although intact rhLT did not. The interaction between desialylated rhLT and uromodulin was inhibited by N,N'-diacetylchitobiose and [Man alpha 1-->6(Man alpha 1-->3)Man alpha 1-->6](Man alpha 1-->2Man alpha 1-->3)Man beta 1-->4GlcNAc beta 1-->4GlcNAc-->Asn. These results indicate that the lectin-like domain of rhLT is exposed on its desialylation.
用人类淋巴毒素(LT)基因组DNA转染的CHO细胞产生的重组人淋巴毒素(rhLT)被纯化至同质,但约5%的分子缺乏最后两个氨基末端残基。用胰蛋白酶切割后,在Asn62(Tr-45)处进行N-糖基化的肽和在Thr7(Tr-14)处部分进行O-糖基化的肽通过反相高效液相色谱法分离。Tr-45的N-连接糖链在肼解(100℃,8小时)后作为寡糖定量释放,随后进行N-乙酰化。用NaB3H4或NaB2H4还原后,通过串联凝集素亲和色谱法、外切糖苷酶消化和甲基化分析相结合的方法确定其结构:82.7%的糖链以双触角复合型糖链形式存在,其余为C-2和C-2,4/C-2,6分支的三触角以及C-2,4和C-2,6分支的四触角复合型糖链,带有岩藻糖基化的甘露糖核心。它们的唾液酸残基仅以Neu5Acα2→3Gal基团的形式存在。去唾液酸化后,rhLT从血液中的清除速度显著加快,并且rhLT倾向于在肾脏中积累,这表明除了肝细胞中的半乳糖结合蛋白和肾脏的过滤系统外,可能还存在其他从循环中清除的机制。去唾液酸化的rhLT表现出与肿瘤坏死因子类似的对尿调节蛋白的凝集素样结合特性,而完整的rhLT则没有。去唾液酸化的rhLT与尿调节蛋白之间的相互作用受到N,N'-二乙酰壳二糖和Manα1→6(Manα1→3)Manα1→6Manβ1→4GlcNAcβ1→4GlcNAc→Asn的抑制。这些结果表明rhLT去唾液酸化后其凝集素样结构域暴露出来。